Investors and Partners
Atlas Venture is a biotech-focused, early-stage venture capital firm that creates and invests in life sciences startup companies in the U.S. Atlas is based in Cambridge, Massachusetts. Since 1993, Atlas has invested in over 150 early stage life sciences companies. For more information, visit www.atlasventure.com.
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For more information, please visit www.biogen.com and follow us on Twitter.
Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder of the Estée Lauder cosmetics family, the Alzheimer’s Drug Discovery Foundation (ADDF) provides funding to leading scientists who are conducting the most promising, innovative Alzheimer’s drug research worldwide. Our goal is to provide seed funding for early-stage research that may otherwise go unfunded. By supporting cutting edge, diverse, novel research projects around the globe, we increase the chance of finding a cure. For more information, visit www.alzdiscovery.org.
About Johnson & Johnson
The Johnson & Johnson Innovation Centers bring together resources from across the Johnson & Johnson Family of Companies to rapidly meet the needs of entrepreneurs and innovators. The team consists of veteran R&D and product development leaders, experienced investors, transactions and legal advisors, and professionals from finance, business development, and communications. Also embedded in each Center are individuals from Johnson & Johnson Development Corporation (JJDC). JJDC uses equity investments and relationships with the private venture community to support innovation and create options in areas of strategic interest to Johnson & Johnson. JJDC is highly focused, investing in areas of strategic importance to the Johnson & Johnson Consumer, Medical Device and Diagnostic, and Pharmaceutical businesses. JJDC invests at very early stages of innovation all the way up to and including proof-of-concept objectives. For more information visit www.jnj.com.
Proteros, Martinsried/Munich, is a privately held company, which provides a leading platform to support protein structure accelerated drug discovery. Proteros has established unique and best in class technologies for protein crystallography, kinetic and thermodynamic profiling and tailor made protein production. Proteros provides services to more than 80 pharmaceutical and biotechnology clients in North America, Europe and Asia. For more information visit www.proteros.com.